News search

    E.g., 03/09/2025
    E.g., 03/09/2025
    Pablo García-Pavía, Nerea Mora Ayestarán y Fernando Domínguez
    Research
    3 Sep 2025
    European Heart Journal: Genes linked to sudden cardiac death increase the risk of heart failure in patients with genetic dilated cardiomyopathy

    Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), together with cardiologists from Hospital Universitario Puerta de Hierro and the Spanish cardiovascular disease research network (CIBERCV), report that the new discovery makes it possible to identify high-risk patients early and refer them sooner to specialized heart failure units
    CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients
    Research
    30 Aug 2025
    NEJM & The Lancet: CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

    REBOOT trial, coordinated by the CNIC, shows that treatment with beta-blockers provides no benefit to patients who experience an uncomplicated heart attack that leaves the contractile function of the heart intact.
    ESC Congress 2025
    About the CNIC
    30 Aug 2025
    EHJ: New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

    The REBOOT study was presented during the European Society of Cardiology Congress (ESC Congress 2025) in Madrid
    ESC Congress 2025 CNIC
    About the CNIC
    26 Aug 2025
    The CNIC at the European Cardiology Congress 2025

    The European Society of Cardiology is holding its annual congress in Madrid from August 29 to September 1
    Pascual Sánchez-Juan
    Research
    13 Aug 2025
    Pascual Sánchez-Juan: “As a clinician, it frustrates me that we don’t see clear benefits for the patient”
    David del Río-Aledo, Rubén Mota, Fátima Sánchez-Cabo, Carlos Torroja, Daniel Morales-Cano, Raúl Izquierdo-Serrano, Paula Nogales, Jesús Mateo, Leticia González-Cintado, Laura Carramolino y Ana Dopazo.
    Research
    12 Aug 2025
    Science Translational Medicine: A hospital imaging technique used in cancer care improves the monitoring and treatment of atherosclerosis

    El 18FDG-PET is a type of positron emission tomography that measures how much energy the body’s cells consume.
    La investigadora Claudia Monaco
    Research
    1 Aug 2025
    Claudia Monaco: “We think we know a lot about cardiovascular disease, but in reality, we don't”

    Dr. Claudia Monaco, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK
    image
    Research
    16 Jul 2025
    Nature: A gut microbiota metabolite linked to atherosclerosis could revolutionise diagnosis and treatment

    A new study led by the CNIC has identified imidazole propionate (ImP), a metabolite produced by gut bacteria, as a driver of atherosclerosis— as a driver of atherosclerosis, the disease behind most heart attacks and strokes
    Marina Rosa Moreno, Fátima Sánchez Cabo, José Luis Cabrera, José Antonio Enríquez, María Concepción Jiménez, Pablo Hernansanz Agustín Lucía Sánchez-García.
    Research
    2 Jul 2025
    Cell Genomics: CNIC scientists reveal how the cellular energy system evolved—and how this knowledge could improve the diagnosis of rare genetic diseases

    CNIC researchers have uncovered the evolutionary logic of the OxPhos system—the cell’s “engine”—and developed a tool to detect mutations that cause mitochondrial disease
    Dr. Eduardo Marbán
    Research
    18 Jun 2025
    Eduardo Marbán: "We have designed a cellular product called Deramiocel, and until now, we have had positive results in at least two clinical trials"